Neil Cashman - Aug 23, 2023 Form 4 Insider Report for ProMIS Neurosciences Inc. (PMN)

Role
Chief Scientific Officer, Director
Signature
/s/ Max A. Milbury, Attorney-in-Fact for Neil Cashman
Stock symbol
PMN
Transactions as of
Aug 23, 2023
Transactions value $
$0
Form type
4
Date filed
8/25/2023, 04:15 PM
Previous filing
Jul 7, 2022
Next filing
Oct 30, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PMN Common Shares Award +10.6K +10.37% 113K Aug 23, 2023 Direct F1
holding PMN Common Shares 1.62K Aug 23, 2023 By his spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PMN Warrants to purchase Common Shares Award +10.6K 10.6K Aug 23, 2023 Common Shares 10.6K $1.75 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On August 23, 2023, pursuant to a Unit Purchase Agreement entered into by the Company with selected investors (the "Offering"), the Reporting Person acquired 10,643 common share units (each, a "Common Share Unit"), each unit consisting of one of the Company's common shares, no par value (the "Common Shares"), and one warrant to purchase one Common Share. The purchase price for each Common Share Unit was $1.88 per Common Share Unit.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney